Suzetrigine for pain after non-mastectomy breast surgery
Treatments studied
Part of Pain, Skin clinical trials.
This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having surgery on one or both breasts that is likely to cause moderate pain (score of 4+ on a 0–10 pain scale)
- You are scheduled to get a single injection of a nerve block during surgery
- You do not take opioids or tramadol daily (if you have, it must have been for less than 2 weeks and not for more than 4 weeks total)
- You do not have a history of opioid misuse or dependence
- You are not currently pregnant, and if you could become pregnant, you are willing to avoid sexual activity or use extra nonhormonal birth control for a month after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new pain medication called suzetrigine can reduce the need for opioids (strong painkillers) after vaginal pelvic reconstructive surgery. The goal is to manage post-surgery pain safely with fewer opioids.
This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.
This trial tests a new medicine, suzetrigine, for managing acute pain in adults who have broken three or more ribs from a blunt injury. It aims to see if this painkiller works well and is safe for you.
This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.
This study tests whether a new pain medication called suzetrigine can help you recover comfortably after a cesarean delivery without needing strong opioid painkillers. You'll receive the study drug and complete follow-up check-ins for two weeks after surgery.
This study tests a new pain medicine called suzetrigine for people having a first-time total knee replacement. The goal is to see if it helps control pain after surgery.
Hear when a new Pain, Acute Postoperative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.